As of 2014, the global pharmaceutical market was worth about $1 trillion US dollars in sales and is expected to increase by US$300 billion within next two years. The ten largest companies with annual sales over $20 billion controlled over one-third of this market. The biggest pharmaceutical companies by sales according to the 2015 edition of Financial Times Global 500 companies are Jonhson & Johnson, Pfizer, Novartis, Roche, and Merck.
The industry is poised for rapid market expansion and R&D growth - which is of particular importance to the pharmaceutical industry - in developing countries such as Brazil, China, and India that could foreshadow a significant market shift for the industry. Today, the pharmaceutical industry, as well as information and communications technology and automobiles, is considered to be a highly R&D intensive sector with an average of 13 percent of net sales dedicated to R&D. Of the world's top 2,500 companies that invested in R&D in 2014 - spending a €607.2 billion, or about 90% of the world's total - 316 were from the pharma & biotech sector. These companies' combined R&D spending accounted for 15 percent of the global R&D investment that year. Moreover, the pharma & biotech industry achieved an R&D spending increase that was 6.8 percent above the world average in 2014.
However significant R&D expenditures are relative to the global net sales of the industry, the R&D price tag is only half as much as pharma companies' expenditures on marketing and far exceeds spending on public information on health. This leads to a conflict of interest between the business goals of manufacturers and social needs to select drugs based on best information available. Pharmaceutical companies have a role to play across several aspects of public health promotion and education, particularly in relation to shifting demographics and deficits in public health care.
The Forbes Global 2000 is an annual ranking of the world’s top 2000 public companies published by Forbes magazine since 2003. The companies are ranked according to four basic metrics: profit, sales, assets and market value.In total, the world's 2000 biggest public companies account for $169 trillion in assets, $35 trillion in revenues, $2 trillion in profits and $48 trillion in market value, according to the 2017 list.The world's largest company by market value is still Apple, however, the technology industry juggernaut from Cupertino is not the leader by the overall score.For the third time, China’s three biggest banks occupied the top...
The Forbes Global 2000 is an annual ranking of the world’s top 2000 public companies published by Forbes magazine since 2003. The companies are ranked according to four basic metrics: profit, sales, assets and market value - and are broken down by industries, including 28 companies from Iron and Steel Industry.In total, the world's 28 biggest public companies from Iron and Steel industry account for $1.62 trillion in assets, $513 billion in revenues, and $300 billion in market value, according to the 2016 list. The world's largest steel company by market value is Citic Pacific, Hong Cong based company.